Home / Remifentanil / Belgium
BE ATC N01AH06 · updated 4 Nov 2026
Remifentanil shortage in Belgium
Is there a Remifentanil shortage in Belgium?
Yes. As of 4 Nov 2026, 1 Remifentanil product is reported short in Belgium, the first since 3 Nov 2026. The company estimate for the return is 7 Dec 2026. Main reason: manufacturing problem.
Also short in United States, Canada, Czechia, Norway, Australia. All countries.
Affected products in Belgium
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| BE | Ultiva 2 mg inj. sol. (pwdr., conc.) i.v. vial 5 x 2 mg | Aspen Pharma Trading | 3 Nov 2026 | 7 Dec 2026 | Manufacturing problem Delay in production |
Source
FAMHP (Federal Agency for Medicines and Health Products), PharmaStatus / SAMv2. Official list. All authorised packs with a declared temporary unavailability.